Aytu Biopharma Cash Flow Statement (2010-2026) | AYTU

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Feb2014 May2014 Sep2014 Dec2014 Feb2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-18.74M-27.85M-11.55M-53.29M-16.09M-0.70M-6.69M-7.20M-2.58M-0.65M-0.84M-0.60M-1.24M0.38M0.12M0.05M0.06M
Depreciation and Depletion (Quarter)
0.50M0.40M0.40M0.50M0.30M0.30M0.40M0.30M0.30M0.30M0.30M0.20M0.10M0.10M0.10M0.10M0.10M0.10M0.10M
Share-based Compensation (Quarter)
1.09M1.52M1.23M1.27M1.23M1.18M3.07M0.90M0.90M0.93M0.82M0.81M0.78M0.17M0.15M0.56M0.11M0.28M0.15M
Deferred Taxes (Quarter)
Gains from Sales and Divestitures (Quarter)
0.16M0.07M0.00M0.11M0.02M0.01M333.000.04M0.00M0.01M0.01M0.00M0.00M564.000.01M0.01M0.01M0.00M0.08M0.08M
Gains from Investment Securities (Quarter)
0.06M0.04M0.01M0.08M0.03M74.000.05M0.05M-1.00M0.08M0.15M1.05M0.45M1.06M0.21M0.00M
Asset Writedowns and Impairment (Quarter)
8.54M19.45M0.10M45.20M10.81M0.10M0.10M2.15M0.10M0.10M0.10M1.09M0.07M0.10M0.10M0.14M0.28M0.80M0.70M
Non-cash Items (Quarter)
0.40M0.30M0.30M0.20M0.05M0.10M0.00M0.20M0.10M0.30M0.02M0.02M0.20M0.06M0.08M0.20M0.10M0.10M0.14M0.15M
Cash from Operations (Quarter)
-6.31M-3.79M-8.82M-9.12M-7.09M-9.10M-2.50M-2.89M9.37M-0.21M-0.14M-0.25M-0.79M-1.19M2.90M-6.46M2.80M-0.62M3.67M-4.18M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
19.50M
Amortization of Deferred Charges (Quarter)
-0.16M-0.16M-0.17M0.10M0.14M0.14M0.17M0.10M0.15M0.15M0.15M0.16M0.13M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Depreciation & Amortization (CF) (Quarter)
3.32M2.68M2.67M2.57M2.22M2.30M2.21M2.19M2.12M2.23M1.79M1.53M1.56M1.33M1.29M1.29M1.46M0.80M0.89M1.12M
Change in Working Capital
Change in Receivables (Quarter)
0.22M-6.53M1.34M4.54M-5.89M6.21M-2.38M8.50M-5.18M0.94M-0.12M-1.03M-5.73M-0.48M2.27M10.51M-4.67M2.07M-2.30M-6.43M
Change in Inventory (Quarter)
-7.18M0.18M0.39M-0.66M-1.21M2.10M0.08M0.80M0.62M1.02M0.68M1.01M2.01M-0.33M-0.63M0.06M0.52M-1.06M-0.61M-0.54M
Change in Account Payables (Quarter)
2.91M-9.89M6.58M-4.79M0.42M3.59M-4.42M4.56M-1.34M0.91M-4.01M0.85M0.13M3.14M-1.81M0.40M-1.44M1.74M-1.08M-1.04M
Change in Accured Expenses (Quarter)
3.06M3.33M-3.94M1.87M-14.54M-3.48M2.47M8.04M-3.43M-5.17M1.27M0.16M-5.77M-4.97M7.31M1.61M-3.06M-1.64M3.46M-5.89M
Other Working Capital Changes (Quarter)
0.01M-0.28M0.01M0.01M-0.01M26.00100.00175.001.79M34.00615.00702.003.52M-0.10M-0.20M0.00M0.81M0.00M0.00M0.01M
Investing Activities
Capital Expenditures (Quarter)
-13.06M0.33M0.14M0.01M0.07M0.02M0.02M
Sales of Property, Plant and Equipment (Quarter)
0.52M0.15M
Acquisitions (Quarter)
-0.20M
Cash from Investing Activities (Quarter)
-2.43M-0.09M-3.05M-0.07M-0.04M0.04M-0.01M0.00M-0.15M-0.08M-0.17M-0.04M-0.03M0.38M0.14M-0.07M-3.02M-0.02M
Financing Activities
Other financing activities (Quarter)
-0.86M0.01M1.23M1.27M5.25M1.18M3.07M0.90M0.93M0.82M0.81M2.75M0.17M0.15M0.14M0.05M0.11M0.28M0.15M
Cash from Financing Activities (Quarter)
11.81M-5.46M6.59M1.52M-1.12M13.56M-1.86M2.58M-5.40M-2.73M-0.13M0.53M1.07M0.91M-2.76M4.30M12.99M2.30M-6.26M0.87M
Additional items
Change in Cash (Quarter)
3.11M-9.34M-5.28M-7.66M-8.25M4.45M-4.31M-0.32M3.81M-3.02M-0.43M0.23M0.25M0.10M0.29M-2.23M12.78M1.68M-2.60M-3.31M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)
6.75M-3.79M-8.82M-9.12M-7.09M-9.10M-2.50M-2.89M9.37M-0.21M-0.14M-0.25M-1.12M-1.33M2.90M-6.52M2.79M-0.62M3.66M-4.18M
Net Cash Flow (Quarter)
3.08M-9.34M-5.28M-7.66M-8.25M4.50M-4.37M-0.31M3.81M-3.02M-0.43M0.23M0.25M0.10M0.29M-2.23M12.78M1.68M-2.60M-3.31M